Advertisement
Organisation › Details
Precision for Medicine (US)
Precision for Medicine supports life sciences companies in the use of biomarkers essential to targeting patients more precisely and effectively. Precision applies novel biomarker approaches to clinical research that take advantage of the latest advancements in science and technology, focusing predominantly around genomics, immune-response assays, global specimen logistics, biomarker analytics, and companion diagnostics solutions. Precision for Medicine is part of Precision Medicine Group, with more than 900 employees in over 15 locations in the US, Canada, and Europe. *
Start | 2012-01-01 established | |
Group | Precision Medicine Group (Group) | |
Industry | analytical services | |
Industry 2 | drug development services | |
Person | Clein, Mark P. (Precision for Medicine 2012– CEO + Co-Founder before United BioSource Corp) | |
City | n. a. Bethesda, MD | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | E: 501 to 1,000 (2018-05-03) |
* Document for »About Section«: Precision for Medicine. (10/4/17). "Press Release: Precision for Medicine Acquires Epiontis – a Leading Immune Monitoring and Epigenetic Technology Service Provider". Bethesda, MD & Berlin. | ||
Record changed: 2023-07-10 |
Advertisement
More documents for Precision Medicine Group (Group)
- [1] Quell Therapeutics Ltd.. (1/6/22). "Press Release: Quell Therapeutics Announces Presentation at the 40th Annual J.P. Morgan Healthcare Conference". London & Boston, MA....
- [2] iTeos Therapeutics S.A.. (2/27/20). "Press Release: iTeos Therapeutics Initiates Phase 1/2 Study with Highly Innovative Anti-TIGIT Antibody in Patients with Advanced Cancers". Cambridge, MA & Gosselies....
- [3] Argen-X N.V. (Argenx). (11/13/17). "Press Release: Argenx to Present at Upcoming Investor Conferences". Breda & Ghent....
- [4] Precision for Medicine. (10/4/17). "Press Release: Precision for Medicine Acquires Epiontis – a Leading Immune Monitoring and Epigenetic Technology Service Provider". Bethesda, MD & Berlin....
- [5] Pharnext S.A.. (9/5/17). "Press Release: Pharnext to Present at Rodman & Renshaw 19th Annual Global Investment Conference". Paris....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement
» top